Información relativa al paciente del fármaco Ethinyl estradiol y norgestrel revisada por un médico - incluye descripción, efectos secundarios (o reacciones adversas), posología e instrucciones de uso.
Ethinyl estradiol is an estrogen, insoluble in water, soluble in alcohol, in chloroform, in ether, in vegetable oils, and in solutions of fixed alkali hydroxides with the chemical name 19-nor-17α;-pregna-1,3,5(10)-trien-20-yne-3,17-diol. Their structural formulae follow: Therapeutic ...
Ethinyl Estradiol; Norgestrel drug usage statistics for the United States (2013 - 2022). Statistics include drug synonyms and therapeutic classes, including: Norgestrel; Ethinyl Estradiol, Ethinyl Estradiol; Norgestrel, Cryselle, Elinest, LO/Ovral, LO/Ov
Generic Name:lvonorgestrel/ethinyl estradiol and ethinyl estradiol tablets Brand Name:Amethia Drug Class:Contraceptives, Oral,Estrogens/Progestins Medical Editor:John P. Cunha, DO, FACOEPLast updated on RxList:5/31/2022 homedrugs a-z listamethia (lvonorgestrel/ethinyl estradiol and ethinyl estradi...
Ethinylestradiol/norgestrelNo Abstract available for this article.doi:10.1007/s40278-016-20687-1NoneSpringer International PublishingReactions Weekly
美国上市药品目录集提供Norgestrel And Ethinyl Estradiol的基本信息,包括Norgestrel And Ethinyl Estradiol的申请号201828,申请类型,活性成分Ethinyl Estradiol; Norgestrel,中文名称炔雌醇;甲基炔诺酮,申请机构,批准日期等药品信息,更多美国药品Norgestrel And Ethinyl E
药品名称:OVRAL,活性成分:ETHINYL ESTRADIOL; NORGESTREL,剂型:TABLET;ORAL-21,规格:0.05MG;0.5MG,药品注册申请号:016672,产品号:001
戊戌数据药品标准数据库提供了Norgestrel and Ethinylestradiol Tablets日本药典标准的查询检索,包括Norgestrel and Ethinylestradiol Tablets日本药典的版本JP15页码,以及药典的查询与下载.
Possible mechanisms of action of a combination of ethinylestradiol (EE) and dl-norgestrel as a postcoital contraceptive agent were studied in 12 healthy female volunteers. An oral dose of 0.1 mg of EE and 1.0 mg of dl-norgestrel was given at the predicted time of ovulation and again 12 ...
Six hundred and eight women were treated with 200 μg of ethinylestradiol and 2 mg of dl-norgestrel, administered in two divided doses, as a postcoital contraceptive. Criteria for entry into the study included definite unprotected coital exposure within the previous 72 hours and the absence of...